Primary record
(5~{s},6~{r},7~{e},9~{e},11~{z},14~{z})-6-[(2~{r})-2-Azanyl-3-(2-Hydroxy-2-Oxoethylamino)-3-Oxidanylidene-Propyl]sulfanyl-5-Oxidanyl-Icosa-7,9,11,14-Tetraenoic Acid
- 库存
- 8,294 克
- 纯度
- 99.4 %
- CAS
- 73836-78-9
化合物标识与属性
- CAS
- 73836-78-9
- PubChem CID
- 5280878
- SMILES
- CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)N
- Canonical SMILES
- CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](N)C(=O)NCC(=O)O)[C@@H](O)CCCC(=O)O
名称与同义词
- leukotriene D4
- Leukotriene D
- LTD4
- Leukotriene D 4
- Leukotriene D-4
- Leukotrienes D
- 73836-78-9
- Leukotriene D(sub 4)
- LEUKOTRIENED4
- AC1NQXPJ
- LTD (sub 4)
- LTD4 (Leukotriene D4)
- RefChem:153158
- 5FNY4416UE
- UNII-5FNY4416UE
- 11-trans Leukotriene D4
- DTXSID6040533
- C25H40N2O6S
- CHEBI:28666
- Epitope ID:688611
- CHEMBL288943
- BSPBio_001368
- LEUKOTRIENE D4 [MI]
- YEESKJGWJFYOOK-IJHYULJSSA-N
- orb1984910
- DTXCID4020533
- SCHEMBL12795157
- MFCD00036839
- HMS3402E10
- ZINC4632133
- 1825AH
- BDBM50292408
- C25-H40-N2-O6-S
- EX-A10473
- LMFA03020006
- AKOS040756242
- CID5280878
- DB11858
- CID:5280878
- NCGC00163399-01
- NCGC00163399-02
- 5S-hydroxy-6R-(S-cysteinylglycinyl)-7E,9E,11E,14Z-eicosatetraenoic acid
- SID:53787561
- HY-113456
- J264.599H
- CS-0059612
- NS00069905
- LEUKOTRIENE D4 (SOLUTION IN ETHANOL)
- C05951
- G91533
- 29821-EP2270008A1
- 29821-EP2272832A1
- 29821-EP2281815A1
- 29821-EP2281819A1
- 29821-EP2292617A1
- 29821-EP2292619A1
- 29821-EP2305640A2
- 29821-EP2305659A1
- 29821-EP2311818A1
- 29821-EP2311832A1
- 29821-EP2311833A1
- D017998
- Q647917
- (5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid
- A1037456
- (R-(R*,S*-(E,E,Z,Z)))-N-(S-(1-(4-Carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-L-cysteinyl)glycine
- 5S-Hydroxy-6R-(S-cysteinylglycinyl)-7E,9E,11Z,14Z-eicosatetraenoic acid
- Glycine, N-(S-(1-(4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-L-cysteinyl)-, (R-(R*,S*-(E,E,Z,Z)))-
- S-{(1R,2E,4E,6Z,9Z)-1-[(1S)-4-carboxy-1-hydroxybutyl]pentadeca-2,4,6,9-tetraen-1-yl}-L-cysteinylglycine
- (5~{s},6~{r},7~{e},9~{e},11~{z},14~{z})-6-[(2~{r})-2-Azanyl-3-(2-Hydroxy-2-Oxoethylamino)-3-Oxidanylidene-Propyl]sulfanyl-5-Oxidanyl-Icosa-7,9,11,14-Tetraenoic Acid
- Glycine, S-[(1R,2E,4E,6Z,9Z)-1-[(1S)-4-carboxy-1-hydroxybutyl]-2,4,6,9-pentadecatetraen-1-yl]-L-cysteinyl-
- LTD
- (5S,6R,7E,9E,11Z,14Z)-6-(((2R)-2-Amino-3-((Carboxymethyl)Amino)-3-Oxopropyl)Sulfanyl)-5-Hydroxyicosa-7,9,11,14-Tetraenoic Acid
- (5S,6R,7E,9E,11Z,14Z)-6-((2-amino-2-((carboxymethyl)carbamoyl)ethyl)sulfanyl)-5-hydroxyicosa-7,9,11,14-tetraenoic acid
- (5S,6R,7E,9E,11Z,14Z)-6-((2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl)sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid
- (5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-amino-3-(carboxymethylamino)-3-oxo-propyl]sulfanyl-5-hydroxy-icosa-7,9,11,14-tetraenoic acid
- (5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-amino-2-[(carboxymethyl)carbamoyl]ethyl]sulfanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid
- (R-(R*,S*-(E,E,Z,Z)))-N-(S-(1-(4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-L-cysteinyl)-glycine
- 79768-40-4
- GLYCINE, S-((1R,2E,4E,6Z,9Z)-1-((1S)-4-CARBOXY-1-HYDROXYBUTYL)-2,4,6,9-PENTADECATETRAEN-1-YL)-L-CYSTEINYL-
- N-[S-[(1R,2E,4E,6Z,9Z)-1-[(1S)-1-Hydroxy-4-carboxybutyl]-2,4,6,9-pentadecatetraene-1-yl]-L-cysteinyl]glycine
- N-[S-[(1R,2E,4E,6Z,9Z)-1-[(1S)-1-Hydroxy-4-carboxybutyl]-2,4,6,9-pentadecatetren-1-yl]-L-cysteinyl]glycine
- N-[S-[(1R,2E,4E,6Z,9Z)-1-[(S)-4-Carboxy-1-hydroxybutyl]-2,4,6,9-pentadecatetren-1-yl]-L-cysteinyl]glycine
- S-((1R,2E,4E,6Z,9Z)-1-((1S)-4-CARBOXY-1-HYDROXYBUTYL)-2,4,6,9-PENTADECATETRAENYL)-L-CYSTEINYLGLYCINE
- S-((1R,2E,4E,6Z,9Z)-1-((1S)-4-Carboxy-1-Hydroxybutyl)Pentadeca-2,4,6,9-Tetraen-1-Yl)-L-Cysteinylglycine
- S-[(1R,2E,4E,6Z,9Z)-1-[(S)-4-Carboxy-1-hydroxybutyl]-2,4,6,9-pentadecatetren-1-yl]-L-Cys-Gly-OH
- S-[(4S,5R,6E,8E,10Z,13Z)-1-Carboxy-4-hydroxynonadeca-6,8,10,13-tetraen-5-yl]-L-cysteinylglycine